Ferroptosis: Promising approach for cancer and cancer immunotherapy

Ferroptosis is the cell death induced by ferrous ions and lipid peroxidation accumulation in tumor cells. Targeting ferroptosis, which is regulated by various metabolic and immune elements, might become a novel strategy for anti-tumor therapy. In this review, we will focus on the mechanism of ferrop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2023-05, Vol.561, p.216152-216152, Article 216152
Hauptverfasser: Zheng, Shuyue, Guan, Xin-Yuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 216152
container_issue
container_start_page 216152
container_title Cancer letters
container_volume 561
creator Zheng, Shuyue
Guan, Xin-Yuan
description Ferroptosis is the cell death induced by ferrous ions and lipid peroxidation accumulation in tumor cells. Targeting ferroptosis, which is regulated by various metabolic and immune elements, might become a novel strategy for anti-tumor therapy. In this review, we will focus on the mechanism of ferroptosis and its interaction with cancer and tumor immune microenvironment, especially for the relationship between immune cells and ferroptosis. Also, we will discuss the latest preclinical progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy, and the best potential conditions for their combined use. It will present a future insight on the possible value of ferroptosis in cancer immunotherapy. •We discuss the latest therapeutic progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy.•We use the concepts of "cold tumor" and "hot tumor" innovatively to discuss the relationship between immunotherapy and ferroptosis.
doi_str_mv 10.1016/j.canlet.2023.216152
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2798709400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383523001039</els_id><sourcerecordid>2798709400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-ece3c7cc9ca8cbb452dd4842cecee64bfcc38f29480fdfbd751d182f4c530aeb3</originalsourceid><addsrcrecordid>eNp9kE9Lw0AQxRdRtFa_gUiOXlL3X5qNB0GKVaGgBz0vm9mJ3dJk424q-O3dEvXoaQbmvXkzP0IuGJ0xyubXmxmYbovDjFMuZpzNWcEPyISpkudlpeghmVBBZS6UKE7IaYwbSmkhy-KYnIgyeSqhJmSxxBB8P_jo4k32EnzrouveM9P3wRtYZ40PWQoCDJnp7G_r2nbX-WGNwfRfZ-SoMduI5z91St6W96-Lx3z1_PC0uFvlIOZ8yBFQQAlQgVFQ17Lg1kolOaQBzmXdAAjV8Eoq2timtmXBLFO8kVAIarAWU3I17k2nfewwDjodC7jdmg79Lmqe3i5pJSlNUjlKIfgYAza6D6414Uszqvf49EaP-PQenx7xJdvlT8KubtH-mX55JcHtKMD056fDoCM4TEisCwiDtt79n_ANowiEVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2798709400</pqid></control><display><type>article</type><title>Ferroptosis: Promising approach for cancer and cancer immunotherapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zheng, Shuyue ; Guan, Xin-Yuan</creator><creatorcontrib>Zheng, Shuyue ; Guan, Xin-Yuan</creatorcontrib><description>Ferroptosis is the cell death induced by ferrous ions and lipid peroxidation accumulation in tumor cells. Targeting ferroptosis, which is regulated by various metabolic and immune elements, might become a novel strategy for anti-tumor therapy. In this review, we will focus on the mechanism of ferroptosis and its interaction with cancer and tumor immune microenvironment, especially for the relationship between immune cells and ferroptosis. Also, we will discuss the latest preclinical progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy, and the best potential conditions for their combined use. It will present a future insight on the possible value of ferroptosis in cancer immunotherapy. •We discuss the latest therapeutic progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy.•We use the concepts of "cold tumor" and "hot tumor" innovatively to discuss the relationship between immunotherapy and ferroptosis.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2023.216152</identifier><identifier>PMID: 37023938</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Cell Death ; Drug Delivery Systems ; Ferroptosis ; Humans ; Immunotherapy ; Neoplasms - therapy ; Tumor Microenvironment</subject><ispartof>Cancer letters, 2023-05, Vol.561, p.216152-216152, Article 216152</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-ece3c7cc9ca8cbb452dd4842cecee64bfcc38f29480fdfbd751d182f4c530aeb3</citedby><cites>FETCH-LOGICAL-c362t-ece3c7cc9ca8cbb452dd4842cecee64bfcc38f29480fdfbd751d182f4c530aeb3</cites><orcidid>0000-0002-4805-0483 ; 0000-0003-1874-9805</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.canlet.2023.216152$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37023938$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Shuyue</creatorcontrib><creatorcontrib>Guan, Xin-Yuan</creatorcontrib><title>Ferroptosis: Promising approach for cancer and cancer immunotherapy</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Ferroptosis is the cell death induced by ferrous ions and lipid peroxidation accumulation in tumor cells. Targeting ferroptosis, which is regulated by various metabolic and immune elements, might become a novel strategy for anti-tumor therapy. In this review, we will focus on the mechanism of ferroptosis and its interaction with cancer and tumor immune microenvironment, especially for the relationship between immune cells and ferroptosis. Also, we will discuss the latest preclinical progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy, and the best potential conditions for their combined use. It will present a future insight on the possible value of ferroptosis in cancer immunotherapy. •We discuss the latest therapeutic progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy.•We use the concepts of "cold tumor" and "hot tumor" innovatively to discuss the relationship between immunotherapy and ferroptosis.</description><subject>Cell Death</subject><subject>Drug Delivery Systems</subject><subject>Ferroptosis</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Neoplasms - therapy</subject><subject>Tumor Microenvironment</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9Lw0AQxRdRtFa_gUiOXlL3X5qNB0GKVaGgBz0vm9mJ3dJk424q-O3dEvXoaQbmvXkzP0IuGJ0xyubXmxmYbovDjFMuZpzNWcEPyISpkudlpeghmVBBZS6UKE7IaYwbSmkhy-KYnIgyeSqhJmSxxBB8P_jo4k32EnzrouveM9P3wRtYZ40PWQoCDJnp7G_r2nbX-WGNwfRfZ-SoMduI5z91St6W96-Lx3z1_PC0uFvlIOZ8yBFQQAlQgVFQ17Lg1kolOaQBzmXdAAjV8Eoq2timtmXBLFO8kVAIarAWU3I17k2nfewwDjodC7jdmg79Lmqe3i5pJSlNUjlKIfgYAza6D6414Uszqvf49EaP-PQenx7xJdvlT8KubtH-mX55JcHtKMD056fDoCM4TEisCwiDtt79n_ANowiEVQ</recordid><startdate>20230501</startdate><enddate>20230501</enddate><creator>Zheng, Shuyue</creator><creator>Guan, Xin-Yuan</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4805-0483</orcidid><orcidid>https://orcid.org/0000-0003-1874-9805</orcidid></search><sort><creationdate>20230501</creationdate><title>Ferroptosis: Promising approach for cancer and cancer immunotherapy</title><author>Zheng, Shuyue ; Guan, Xin-Yuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-ece3c7cc9ca8cbb452dd4842cecee64bfcc38f29480fdfbd751d182f4c530aeb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cell Death</topic><topic>Drug Delivery Systems</topic><topic>Ferroptosis</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Neoplasms - therapy</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Shuyue</creatorcontrib><creatorcontrib>Guan, Xin-Yuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Shuyue</au><au>Guan, Xin-Yuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ferroptosis: Promising approach for cancer and cancer immunotherapy</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2023-05-01</date><risdate>2023</risdate><volume>561</volume><spage>216152</spage><epage>216152</epage><pages>216152-216152</pages><artnum>216152</artnum><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Ferroptosis is the cell death induced by ferrous ions and lipid peroxidation accumulation in tumor cells. Targeting ferroptosis, which is regulated by various metabolic and immune elements, might become a novel strategy for anti-tumor therapy. In this review, we will focus on the mechanism of ferroptosis and its interaction with cancer and tumor immune microenvironment, especially for the relationship between immune cells and ferroptosis. Also, we will discuss the latest preclinical progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy, and the best potential conditions for their combined use. It will present a future insight on the possible value of ferroptosis in cancer immunotherapy. •We discuss the latest therapeutic progress of the collaboration between the ferroptosis-targeted drugs and immunotherapy.•We use the concepts of "cold tumor" and "hot tumor" innovatively to discuss the relationship between immunotherapy and ferroptosis.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>37023938</pmid><doi>10.1016/j.canlet.2023.216152</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4805-0483</orcidid><orcidid>https://orcid.org/0000-0003-1874-9805</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2023-05, Vol.561, p.216152-216152, Article 216152
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_2798709400
source MEDLINE; Elsevier ScienceDirect Journals
subjects Cell Death
Drug Delivery Systems
Ferroptosis
Humans
Immunotherapy
Neoplasms - therapy
Tumor Microenvironment
title Ferroptosis: Promising approach for cancer and cancer immunotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A42%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ferroptosis:%20Promising%20approach%20for%20cancer%20and%20cancer%20immunotherapy&rft.jtitle=Cancer%20letters&rft.au=Zheng,%20Shuyue&rft.date=2023-05-01&rft.volume=561&rft.spage=216152&rft.epage=216152&rft.pages=216152-216152&rft.artnum=216152&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2023.216152&rft_dat=%3Cproquest_cross%3E2798709400%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2798709400&rft_id=info:pmid/37023938&rft_els_id=S0304383523001039&rfr_iscdi=true